Pa. court reinstates $28M punitive award in HRT case 
Published: January 10, 2012
Tags: breast cancer, HRT litigation, Premarin, Prempro, product liability, Provera, Upjohn, Wyeth
A $28 million award of punitive damages was not unconstitutionally excessive in a product liability case brought by a woman who contracted breast cancer after taking hormone replacement therapy drugs, a Pennsylvania appellate court has ruled in reversing judgment.
HRT litigation rolls on
By:
Nora Tooher
Published: August 31, 2010
Tags: hormone replacement therapy litigation, Pfizer, Premarin, Prempro, Provera, Upjohn, Wyeth
With Pfizer and plaintiffs’ lawyers squabbling over who has won the most hormone replacement therapy trials, only one thing about the litigation is clear: it’s turning into one of the longest-running mass torts in U.S. history.
SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?
If not, click here to register and learn more now.
